The glucocorticoid receptor blocks P-TEFb recruitment by NFκB to effect promoter-specific transcriptional repression

  1. Hans F. Luecke and
  2. Keith R. Yamamoto1
  1. Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, California 94107-2280, USA

Abstract

To investigate the determinants of promoter-specific gene regulation by the glucocorticoid receptor (GR), we compared the composition and function of regulatory complexes at two NFκB-responsive genes that are differentially regulated by GR. Transcription of the IL-8 and IκBα genes is stimulated by TNFα in A549 cells, but GR selectively represses IL-8 mRNA synthesis by inhibiting Ser2 phosphorylation of the RNA polymerase II (pol II) C-terminal domain (CTD). The proximal κB elements at these genes differ in sequence by a single base pair, and both recruited RelA and p50. Surprisingly, GR was recruited to both of these elements, despite the fact that GR failed to repress the IκBα promoter. Rather, the regulatory complexes formed at IL-8 and IκBα were distinguished by differential recruitment of the Ser2 CTD kinase, P-TEFb. Disruption of P-TEFb function by the Cdk-inhibitor, DRB, or by small interfering RNA selectively blocked TNFα stimulation of IL-8 mRNA production. GR competed with P-TEFb recruitment to the IL-8 promoter. Strikingly, IL-8 mRNA synthesis was repressed by GR at a post-initiation step, demonstrating that promoter proximal regulatory sequences assemble complexes that impact early and late stages of mRNA synthesis. Thus, GR accomplishes selective repression by targeting promoter-specific components of NFκB regulatory complexes.

Keywords

Footnotes

  • Supplemental material is available at http://www.genesdev.org.

  • Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.1297105.

  • 1 Corresponding author.

    1 E-MAIL yamamoto{at}cmp.ucsf.edu; FAX (415) 476-6129.

    • Accepted March 16, 2005.
    • Received January 11, 2005.
| Table of Contents

G&D Most Read

View all ...

follow us on twitter

Life Science Alliance